Home New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug
 

Keywords :   


New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug

2013-10-14 06:06:15| Biotech - Topix.net

A New Zealand biotechnology company, CuroNZ, received funding from the US National Multiply Sclerosis Society worth $540,000 to be used in pre-clinical studies.

Tags: multiple firm drug zealand

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11topps now psa10
27.11 THE ORAL CIGARETTES SUCK MY WORLD
27.11 E
27.113DS .SD()
27.11181
27.11YAMAHA KUSHITANI LL
27.11tsnomi.com
27.11
More »